FGF9 and triple-A syndrome: Associations were consistent with known AAA pathobiology, implicating lipoprotein metabolism, inflammation, and matrix metalloproteinases but also identified potentially novel mechanisms relating to genes such as ERG and FGF9. This study has identified novel, potentially disease-specific, genetic associations with AAA.